Field Medical Unveils Promising Results of First VCAS Human Trial for Ventricular Ablation Field Medical's FieldForce™ Ablation System shows significant promise in treating ventricular tachycardia, presenting 82% reduction in recurrences and 98% decrease in episodes.

Field Medical Unveils Promising Results of First VCAS Human Trial for Ventricular Ablation #United_States #New_York #Field_Medical #FieldForce #VCAS_trial